USPSTF 2023: Screening recommended for anxiety in adults, including in pregnant and postpartum persons (B recommendation)

Clinical Question

Should primary care clinicians screen asymptomatic adults for anxiety disorders?

Bottom line

In this first-time evidence review, the USPSTF recommends screening for anxiety disorders in asymptomatic adults, 19 to 64 years, including pregnant and postpartum persons (B recommendation). The task force further concludes that evidence is insufficient to assess the balance of benefits and harms of screening for anxiety disorders in adults 65 years or older (I statement). As with depression screening, it is important that persons who screen positive are evaluated further and, if appropriate, provided or referred for appropriate treatment. 2c

Study design: Practice guideline

Funding: Government

Setting: Various (guideline)

Reviewer

David C. Slawson, MD
Professor and Vice Chair of Family Medicine for Education and Scholarship
Atrium Health
Professor of Family Medicine, UNC Chapel Hill
Charlotte, NC


Discuss this POEM


Comments

Arup Kumar Dhara

Impact assessment

Excellent

Anonymous

SCREENING ANXIETY IN ADULT PATIENTS

GOOD TO KNOW

Robert Wallace Shepherd

USPSTF 2023 recomended screening for anxiety in adults.

The US Preventive Services Task Force found no direct evidence showing a benefit in screening for anxiety disorders. Nonetheless, the Task Force recommended screening for anxiety. There is no logic behind this recommendation.

Anonymous

Screening for anxiety

If there seem to be no benefits and no risks to screening, why would we call this a B recommendation?